You are here

Biblio

Export 78 results:
[ Author(Desc)] Title Type Year
Filters: Keyword is Risk  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
Barzilay JI, Bůzková P, Cauley JA, Robbins JA, Fink HA, Mukamal KJ. The associations of subclinical atherosclerotic cardiovascular disease with hip fracture risk and bone mineral density in elderly adults. Osteoporos Int [Internet]. 2018 ;29(10):2230. Available from: https://www.ncbi.nlm.nih.gov/pubmed/30132027
Bell EJ, Lutsey PL, Basu S, Cushman M, Heckbert SR, Lloyd-Jones DM, Folsom AR. Lifetime Risk of Venous Thromboembolism in Two Cohort Studies. Am J Med. 2016 ;129(3):339.e19-26.
Berry JD, Dyer A, Cai X, Garside DB, Ning H, Thomas A, Greenland P, Van Horn L, Tracy RP, Lloyd-Jones DM. Lifetime risks of cardiovascular disease. N Engl J Med. 2012 ;366(4):321-9.
Brown AF, Liang L-J, Vassar SD, Stein-Merkin S, Longstreth WT, Ovbiagele B, Yan T, Escarce JJ. Neighborhood disadvantage and ischemic stroke: the Cardiovascular Health Study (CHS). Stroke. 2011 ;42(12):3363-8.
Burnett-Hartman AN, Fitzpatrick AL, Kronmal RA, Psaty BM, Jenny NS, Bis JC, Tracy RP, Kimura M, Aviv A. Telomere-associated polymorphisms correlate with cardiovascular disease mortality in Caucasian women: the Cardiovascular Health Study. Mech Ageing Dev. 2012 ;133(5):275-81.
Bůzková P, Barzilay JI, Fink HA, Robbins JA, Cauley JA, Fitzpatrick AL. Ratio of urine albumin to creatinine attenuates the association of dementia with hip fracture risk. J Clin Endocrinol Metab. 2014 ;99(11):4116-23.
C
Cai T, Tian L, Lloyd-Jones D, Wei LJ. Evaluating subject-level incremental values of new markers for risk classification rule. Lifetime Data Anal. 2013 ;19(4):547-67.
Cao JJ, Biggs ML, Barzilay J, Konen J, Psaty BM, Kuller L, Bleyer AJ, Olson J, Wexler J, Summerson J, et al. Cardiovascular and mortality risk prediction and stratification using urinary albumin excretion in older adults ages 68-102: the Cardiovascular Health Study. Atherosclerosis. 2008 ;197(2):806-13.
Carty CL, Heagerty P, Heckbert SR, Jarvik GP, Lange LA, Cushman M, Tracy RP, Reiner AP. Interaction between fibrinogen and IL-6 genetic variants and associations with cardiovascular disease risk in the Cardiovascular Health Study. Ann Hum Genet. 2010 ;74(1):1-10.
Chauhan G, Adams HHH, Bis JC, Weinstein G, Yu L, Töglhofer AMaria, Smith AVernon, van der Lee SJ, Gottesman RF, Thomson R, et al. Association of Alzheimer's disease GWAS loci with MRI markers of brain aging. Neurobiol Aging. 2015 ;36(4):1765.e7-16.
Coresh J, Turin TChowdhury, Matsushita K, Sang Y, Ballew SH, Appel LJ, Arima H, Chadban SJ, Cirillo M, Djurdjev O, et al. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA. 2014 ;311(24):2518-2531.
Cotlarciuc I, Malik R, Holliday EG, Ahmadi KR, Paré G, Psaty BM, Fornage M, Hasan N, Rinne PE, Ikram AM, et al. Effect of genetic variants associated with plasma homocysteine levels on stroke risk. Stroke. 2014 ;45(7):1920-4.
Crainich P, Jenny NS, Tang Z, Arnold AM, Kuller LH, Manolio T, Sharrett AR, Tracy RP. Lack of association of the plasminogen activator inhibitor-1 4G/5G promoter polymorphism with cardiovascular disease in the elderly. J Thromb Haemost. 2003 ;1(8):1799-804.

Pages